(Q39490917)

English

Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

bluetongue virus

0 references

Stéphan Zientara

8

object named as

Stéphan Zientara

0 references

9

object named as

Polly Roy

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Corinne Sailleau

3

object named as

Corinne Sailleau

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

5

object named as

Cyril Viarouge

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Emmanuel Breard

4

object named as

Emmanuel Bréard

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Alexandra Desprat

6

object named as

Alexandra Desprat

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Meredith Stewart

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Eric Dubois

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Richard Thiéry

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

14 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

553-558

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Culicoides and the emergence of bluetongue virus in northern Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Toggenburg Orbivirus, a new bluetongue virus: initial detection, first observations in field and experimental infection of goats and sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Bluetongue in Europe and the Mediterranean Basin: history of occurrence prior to 2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Field observations during the bluetongue serotype 8 epidemic in 2006. I. Detection of first outbreaks and clinical signs in sheep and cattle in Belgium, France and the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Bluetongue in Europe: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Vaccines against bluetongue in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Genetically engineered particulate virus-like structures and their use as vaccine delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Protective efficacy of virus-like particles for bluetongue disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Multigene expression of protein complexes by iterative modification of genomic Bacmid DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Bluetongue in Belgium, 2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

A side effect of decreased fertility associated with vaccination against bluetongue virus serotype 8 in Holstein dairy cows.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Evaluation of interferences between dengue vaccine serotypes in a monkey model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Immunologic interference from sequential administration of live attenuated alphavirus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.016

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.11.016

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39490917&oldid=1951019700"